Workflow
CMS(06099)
icon
Search documents
YiwealthSMI|东方财富蝉联榜首,年末盘点内容频上榜
Di Yi Cai Jing· 2026-02-02 05:12
本期为证券社交媒体指数(2025年12月)。 本期为证券社交媒体指数(2025年12月)。 中信证券TALK 平安训 80.69 03 大同证券 国泰海议 80.51 04 国金证券 中彩顶 79.30 05 财富零 国投证券 79.17 06 渤海证券 山西订 76.42 07 太平洋证券 德邦ü 75.61 08 兴业! 申万宏源投教基地 75.31 09 国信订 中原证券 75.25 10 视频号指数榜 | 排名 | 名称 | 指数 | 雷达图 | 排名 | 名称 | | --- | --- | --- | --- | --- | --- | | 01 | 东方财富 | 81.06 | | 11 | 德邦训 | | 02 | 中信证券 | 77.83 | | 12 | 东方订 | | 03 | 申万宏源投教基地 | 76.80 | | 13 | 金融街 | | 04 | 开源证券 | 75.55 | | 14 | 国金i | | 05 | 广发头条 | 75.49 | | 15 | 长江证券丈 | | 06 | 国泰海通君弘 | 74.42 | | 16 | 招商订 | | 07 | 红塔证券 | 73 ...
康希通信连亏2年 2023上市即巅峰招商证券保荐
Zhong Guo Jing Ji Wang· 2026-02-02 03:22
康希通信募集资金总额为66,864.00万元,募集资金净额为59,967.21万元。康希通信最终募集资金净 额比原计划少18202.96万元。2023年11月14日康希通信发布的首次公开发行股票并在科创板上市招股说 明书显示,公司拟募集资金78,170.17万元,分别用于新一代Wi-Fi射频前端芯片研发及产业化项目、泛 IoT无线射频前端芯片研发及产业化项目、企业技术研发中心建设项目、补充流动资金。 中国经济网北京2月2日讯 康希通信(688653.SH)近日披露2025年年度业绩预告。 经财务部门初步测算,康希通信预计2025年度预计实现营业收入68,350万元左右,与上年同期(法 定披露数据)相比,将增加16,071万元左右,同比增长30.74%左右;实现归属于母公司所有者的净利润 将出现亏损,预计实现归属于母公司所有者的净利润为-4,350万元左右,与上年同期相比,将减少亏损 3,263万元左右,同比减亏42.86%左右;实现归属于母公司所有者的扣除非经常性损益后的净利润 为-6,300万元左右,与上年同期相比,将减少亏损3,320万元左右,同比减亏34.51%左右。 2024年,公司实现营业收入5.2 ...
招商证券国际:重申石药集团(01093)“中性”评级 中国创新药进入全球管线
智通财经网· 2026-02-02 03:13
该行认为siRNA进入肥胖维持市场,将对所有胜肽类方案构成真正威胁。siRNA药物切入减重及肌保市 场,或最终挤压肽基肥胖疗法。该行密切追踪Arrowhead和Wave siRNA资产进展后,认为肥胖维持领域 正日益拥挤。建议投资人关注未来siINHBE和siALK7靶点对减重维持市场的影响。 招商证券国际发布研报称,石药集团(01093)与阿斯利康(AZN.US)达成历史性交易公告,表示看好交 易,但需等待石药或阿斯利康披露更多长效GLP-1全球开发细节。重申"中性"评级,认为短期基本面仍 存隐忧。 该行表示,根据石药最新公告,与阿斯利康合作的关键临床候选药物为SYH2082,长效GLP-1R/GIPR双 激动剂,现已进入I期临床。该行对此长效GLP-1平台了解甚少。SYH2082刚在中国启动I期研究。需等 待管理阶层揭露其设计细节及潜在临床开发路径,方能进行价值量化评估。该行维持"中国创新药进入 全球管线"的长期正面判断,但建议投资者仔细审视BD公告前已被市场计入预期的资产估值因素,并对 双方合作进展进行深度量化评估。 ...
招商证券国际:重申石药集团“中性”评级 中国创新药进入全球管线
Zhi Tong Cai Jing· 2026-02-02 03:01
该行表示,根据石药最新公告,与阿斯利康合作的关键临床候选药物为SYH2082,长效GLP-1R/GIPR双 激动剂,现已进入I期临床。该行对此长效GLP-1平台了解甚少。SYH2082刚在中国启动I期研究。需等 待管理阶层揭露其设计细节及潜在临床开发路径,方能进行价值量化评估。该行维持"中国创新药进入 全球管线"的长期正面判断,但建议投资者仔细审视BD公告前已被市场计入预期的资产估值因素,并对 双方合作进展进行深度量化评估。 该行认为siRNA进入肥胖维持市场,将对所有胜肽类方案构成真正威胁。siRNA药物切入减重及肌保市 场,或最终挤压肽基肥胖疗法。该行密切追踪Arrowhead和Wave siRNA资产进展后,认为肥胖维持领域 正日益拥挤。建议投资人关注未来siINHBE和siALK7靶点对减重维持市场的影响。 招商证券国际发布研报称,石药集团(01093)与阿斯利康(AZN.US)达成历史性交易公告,表示看好交 易,但需等待石药或阿斯利康披露更多长效GLP-1全球开发细节。重申"中性"评级,认为短期基本面仍 存隐忧。 ...
招商证券国际:中国人形机器人2026年呈快步小跑、全链爆发趋势
智通财经网· 2026-02-02 02:45
Core Viewpoint - The report from China Merchants Securities International predicts that the humanoid robot industry in China will experience significant growth by 2026 due to advancements in AI model capabilities, hardware technology maturity, cost reductions, and accelerated application scenarios, along with a surge in orders in the fourth quarter [1] Group 1: Recommended Companies - Recommended humanoid robot manufacturers include UBTECH Robotics (09880), Yujin Robot (02432), and Geek+ (02590) [1] - Cross-industry collaborative companies recommended are Tesla (TSLA.US) and Xpeng Motors (09868) [1] - Ecological companies to watch include Xiaomi Group (01810) and Midea Group (00300) [1] Group 2: Supply Chain Insights - The supply chain outlook is positive, focusing on technology convergence, with a favorable view on Minth Group (00425) in the Hong Kong stock market [1] - Companies expanding from intelligent driving to robotics, such as Hesai Technology (02525) and Horizon Robotics (09660), are also highlighted as promising [1] Group 3: Industry Trends - The humanoid robot industry in China is characterized by rapid incremental advancements and a full-chain explosion, particularly with the trend of large-scale production by overseas leaders by the end of the year [1] - Catalysts for growth include the release of Tesla's V3 and the listing of Yushu Technology, along with a significant number of new robot companies expected to go public in the Hong Kong market this year [1]
招商证券:2月市场轮动或加快 行业配置围绕顺周期+科技领域布局
智通财经网· 2026-02-01 22:57
Market Outlook - The market is expected to remain volatile in February, with indices likely to perform better post-holiday compared to pre-holiday levels [1][2] - The lack of clear catalysts before the Spring Festival is anticipated to reduce market activity, while policy catalysts are expected to accelerate after the holiday due to the upcoming Two Sessions [2] Fundamental Analysis - The period of January to February is characterized as a data vacuum, with market focus on marginal improvements in performance driven by industrial changes [2] - Key sectors include cyclical price increases, particularly in semiconductors and AI-related products, which are expected to maintain a positive trend [2][5] Liquidity and Capital Supply - February is projected to see continued net inflows of incremental capital, with foreign capital expected to flow in before the holiday and financing likely to rebound afterward [4] - The central bank is expected to maintain a stable liquidity environment through targeted measures, despite some liquidity tightening from government bond issuances [4] Industry Recommendations - The report suggests focusing on cyclical and technology sectors, with increased attention on discretionary consumption as the Spring Festival approaches [3][6] - Recommended sectors include electronics (semiconductors), media (advertising, gaming, film), machinery (automation, engineering), power equipment (batteries, grid equipment, photovoltaic), basic chemicals, and social services [3][6] Performance Trends - In January, high-performing sectors included certain resource products, public utilities, and information technology, with notable price increases in industrial metals and chemicals [6] - The report highlights a recovery in profitability for certain sectors, particularly in resource products and TMT (Technology, Media, Telecommunications) driven by AI [5][6]
非银金融行业投资策略周报:券商与保险基本面持续向好,关注非银板块配置价值-20260201
GF SECURITIES· 2026-02-01 06:10
Core Viewpoints - The non-bank financial sector, including brokerage and insurance, shows continued improvement in fundamentals, highlighting the investment value of the non-bank sector [1] Group 1: Market Performance - As of January 31, 2026, the Shanghai Composite Index reported 4117.95 points, down 0.44%, while the Shenzhen Component Index was at 14205.89, down 1.62% [10] - The CSI 300 Index increased by 0.08%, and the ChiNext Index decreased by 0.09% [10] - The CITIC II Securities Index fell by 0.71%, while the CITIC II Insurance Index rose by 5.41% [10] Group 2: Industry Dynamics and Weekly Commentary Insurance Sector - Listed insurance companies are expected to maintain high growth, with a marginal improvement in long-term interest rate spreads [15] - As of January 30, 2026, the 10-year government bond yield was 1.81%, down 2 basis points from the previous week, indicating a cautious risk preference in the equity market [12] - The insurance sector is benefiting from a stable long-term interest rate environment and an upward trend in the equity market, which is expected to drive performance growth in Q1 2026 [15] Securities Sector - The securities market is showing positive core indicators, with a projected high growth in Q1 2026, supported by improved trading volume and margin financing [16] - As of January 30, 2026, 17 brokerages reported a total net profit of 1153.44 billion CNY for 2025, a year-on-year increase of 60.27% [19] - The average daily trading volume of all A and B shares reached 2.90 trillion CNY, a 144.26% increase compared to the same period in 2025, indicating a significant rise in market activity [21] Group 3: Investment Opportunities - The launch of commercial real estate REITs is expected to expand business opportunities, with the first three products anticipated to raise over 13 billion CNY [27] - The REITs initiative aims to activate existing commercial real estate assets and enhance the supply of capital market products, indicating strong market demand [27] - The insurance sector is advised to focus on companies like China Ping An, China Life, and New China Life, which are expected to benefit from favorable market conditions [15]
2025招商证券“招财杯”ETF实盘大赛落幕
Zhong Zheng Wang· 2026-02-01 02:33
转自:中国证券报·中证网 中证报中证网讯(记者 齐金钊)日前,2025招商证券"招财杯"ETF实盘大赛落下帷幕。本届大赛于2025 年4月28日正式启幕,招商证券携手易方达基金、招商基金、博时基金、摩根基金、银华基金、汇添富 基金、华夏基金、国泰基金、广发基金、鹏华基金十大基金公司(排名不分先后),共同为投资者打造 一个集学习、交流、成长于一体的投教平台。据统计,本届大赛浏览量超880万人次,活跃度较上届大 赛增长超六成,实现显著增长。 据悉,为了让更多投资者领略ETF投资的魅力,自2023年起,招商证券已连续三年举办"招财杯"ETF实 盘大赛,累计吸引近27万名选手报名参赛,投教及赛事相关内容累计触达投资者超过千万人次,逐步构 建起良性循环的ETF投资生态圈。 数据显示,2025年"招财杯"ETF实盘大赛报名人数近八万。从重仓板块来看,排名居前的选手们主要在 宽基ETF与生物医药、通信设备、半导体芯片等行业主题ETF中灵活轮动,体现了对市场热点的关注与 配置调整。 招商证券表示,大赛的圆满收官,既是过往成果的总结,更是投资者ETF投资实践的新起点。 招商证 券将始终秉承"用心服务客户,专业创造价值"的核心理 ...
招商证券:茅台动销表现优异,春节备货需求前置,其他品牌承压
Ge Long Hui A P P· 2026-01-31 05:54
格隆汇1月31日|招商证券在最新的一份研究报告中也指出,该团队近期调研了河南、安徽、四川等多 地白酒渠道,总需求仍在下滑(双位数下滑),但符合此前预期。分场景看,商务宴请以小局为主、中 高端餐饮仍较萧条,送礼需求有部分回补。品牌侧分化明显,茅台动销表现优异,春节备货需求前置, 其他品牌承压。 新浪财经"酒价内参"重磅上线 知名白酒真实市场价尽在掌握 ...
招商证券:短期来看,茅台批价的供需关系不改
Xin Lang Cai Jing· 2026-01-31 04:51
Core Viewpoint - The supply-demand relationship for Moutai prices remains unchanged in the short term, with low inventory among distributors and tight supply supporting a potential price increase [1] Short-term Analysis - Moutai's allocation quotas are nearly fulfilled before the year-end, leading to low distributor inventory levels [1] - Demand is expected to grow year-on-year at a double-digit rate, providing support for price increases [1] Long-term Perspective - Currently, the industry is at the bottom of the economic cycle, facing multiple negative constraints such as economic pressure and alcohol bans, which limit demand [1] - The solid bottom of supply-demand balance may lead to the removal of constraints in the future, creating upward price momentum and driving valuation and performance improvements [1]